Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy

Serum growth differentiation factor 15 (GDF-15) levels are elevated in patients with Parkinson’s disease (PD) and may help differentiate these patients from healthy individuals. We aimed to clarify whether serum GDF-15 levels can help differentiate PD from atypical parkinsonian syndromes and determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyaue, Noriyuki, Yabe, Hayato, Nagai, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535128/
https://www.ncbi.nlm.nih.gov/pubmed/37755357
http://dx.doi.org/10.3390/neurolint15030066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535128/
https://www.ncbi.nlm.nih.gov/pubmed/37755357
http://dx.doi.org/10.3390/neurolint15030066

Ejemplares similares